Articles about Oxford

Coronavirus vaccine consignment awaits government nod for take-off from Pune

08 Jan 2021

Coronavirus vaccine consignment awaits government nod for take-off from Pune

On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.

All states to hold dry run for coronavirus vaccination today

02 Jan 2021

All states to hold dry run for coronavirus vaccination today

A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.

Coronavirus: India's daily death toll remained under 300 last week

01 Jan 2021

Coronavirus: India's daily death toll remained under 300 last week

India recorded less than 300 deaths linked to coronavirus every day between last Thursday and today, the government said.

India set to start COVID-19 vaccination; panel approves Oxford vaccine

01 Jan 2021

India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

India could approve coronavirus vaccine soon, key meeting today

01 Jan 2021

India could approve coronavirus vaccine soon, key meeting today

After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.

Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe

09 Dec 2020

Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe

The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.

Serum seeks emergency use approval for Oxford's coronavirus vaccine

07 Dec 2020

Serum seeks emergency use approval for Oxford's coronavirus vaccine

Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said.

SII to sue vaccine trial participant for Rs. 100 crore

30 Nov 2020

SII to sue vaccine trial participant for Rs. 100 crore

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions

26 Nov 2020

Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

Can launch 100 million vaccine doses by January-February, says Poonawalla

23 Nov 2020

Can launch 100 million vaccine doses by January-February, says Poonawalla

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

Oxford's vaccine, India's best shot against coronavirus, is 70% effective

23 Nov 2020

Oxford's vaccine, India's best shot against coronavirus, is 70% effective

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

India relying on five coronavirus vaccines to control pandemic

18 Nov 2020

India relying on five coronavirus vaccines to control pandemic

With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.

Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

05 Nov 2020

Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

29 Oct 2020

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

Oxford COVID-19 vaccine generates immune response among young and old

26 Oct 2020

Oxford COVID-19 vaccine generates immune response among young and old

The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

22 Oct 2020

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

NewsBytes Briefing: US Senate subpoenas CEOs of Google, Facebook, Twitter

02 Oct 2020

NewsBytes Briefing: US Senate subpoenas CEOs of Google, Facebook, Twitter

Last night, the US Senate Commerce Committee voted unanimously to issue subpoenas to the CEOs of Facebook, Google, and Twitter.

Carabao Cup second round in numbers

16 Sep 2020

Carabao Cup second round in numbers

16 matches were held in the second round of the Carabao Cup.

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

16 Sep 2020

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

NewsBytes Briefing: TikTok sale deadline likely to be missed, more

11 Sep 2020

NewsBytes Briefing: TikTok sale deadline likely to be missed, more

Last night, multiple reports suggested that ByteDance is likely to miss the September 20 deadline for finalizing the sale of TikTok's US assets.

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

10 Sep 2020

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

NewsBytes Briefing: TikTok tries to dodge sale, and more

10 Sep 2020

NewsBytes Briefing: TikTok tries to dodge sale, and more

Last night, TikTok was reported to be considering a way out of selling its US business to an American company.

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

10 Sep 2020

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

NewsBytes Briefing: Galaxy Z Fold2 price announced, and more

02 Sep 2020

NewsBytes Briefing: Galaxy Z Fold2 price announced, and more

Last night, Samsung held the second part of Galaxy Unpacked event and gave an in-depth look at its latest foldable phone - the Z Fold2.

NewsBytes Briefing: Reliance buys Netmeds, SpaceX's biggest fund-raise, and more

19 Aug 2020

NewsBytes Briefing: Reliance buys Netmeds, SpaceX's biggest fund-raise, and more

In the last few hours, renowned tech giants took major strides.

Australia secures 'promising' COVID-19 vaccine, will offer it for free

19 Aug 2020

Australia secures 'promising' COVID-19 vaccine, will offer it for free

In a bid to exit the COVID-19 pandemic for good, Australia has secured access to a "promising vaccine."

India likely to have COVID-19 vaccine by December: Adar Poonawalla

11 Aug 2020

India likely to have COVID-19 vaccine by December: Adar Poonawalla

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

Serum Institute's COVID-19 vaccines will come at $3 per dose

07 Aug 2020

Serum Institute's COVID-19 vaccines will come at $3 per dose

In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.

India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

06 Aug 2020

India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

NewsBytes Briefing: William English, computer mouse co-inventor, dies at 91

03 Aug 2020

NewsBytes Briefing: William English, computer mouse co-inventor, dies at 91

A lot has happened over the weekend.

SII gets nod for Oxford COVID vaccine phase 2/3 trials

03 Aug 2020

SII gets nod for Oxford COVID vaccine phase 2/3 trials

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

Six months of coronavirus pandemic, six months that changed India!

30 Jul 2020

Six months of coronavirus pandemic, six months that changed India!

On January 30, television screens flashed reports of the first coronavirus patient in India - a student from Kerala who had returned from China's Wuhan.

'Bhabhiji Papad' can develop antibodies, fight coronavirus: Union Minister

24 Jul 2020

'Bhabhiji Papad' can develop antibodies, fight coronavirus: Union Minister

At a time when the world is scrambling to develop a vaccine against coronavirus, a Union Minister launched a "papad" claiming it develops antibodies to fight the highly contagious disease.

Coronavirus vaccine will be available by 2021? Adar Poonawalla hopeful

22 Jul 2020

Coronavirus vaccine will be available by 2021? Adar Poonawalla hopeful

Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.

In just 100 hours, world added 1 million coronavirus cases

18 Jul 2020

In just 100 hours, world added 1 million coronavirus cases

A respite for the world battling the coronavirus pandemic, looks far-fetched, considering how easily the disease is spreading.

#GoodNews: Oxford's COVID-19 vaccine may be available by September-end

17 Jul 2020

#GoodNews: Oxford's COVID-19 vaccine may be available by September-end

The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.

COVID-19 vaccine: What are the latest updates?

05 Jul 2020

COVID-19 vaccine: What are the latest updates?

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

COVID-19: Who will be the first ones to get vaccinated?

26 Jun 2020

COVID-19: Who will be the first ones to get vaccinated?

COVID-19 has wreaked havoc around the world, leaving everyone desperate for a vaccine - a much-needed shot that prevents contraction or at least mitigates the severe impact of the novel coronavirus.

COVID-19 vaccine: What are the latest updates?

07 Jun 2020

COVID-19 vaccine: What are the latest updates?

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.

Coronavirus wiped nearly a quarter of Indian billionaires' wealth: Forbes

06 May 2020

Coronavirus wiped nearly a quarter of Indian billionaires' wealth: Forbes

The outbreak of COVID-19, which has claimed over 2.5 lakh lives and put a third of the world's population under lockdown, has wrecked economies completely.